Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKrm22 Plc Regulatory News (KRM)

Share Price Information for Krm22 Plc (KRM)

Share Price is delayed by 15 minutes
Get Live Data
32.50    0.00 (0.00%)
Bid:
32.00
Ask:
33.00
Spread: 1.00 (3.125%)
Market Cap: £19.28m
KRM Live PriceLast checked at - London Stock Exchange

Intraday Krm22 Plc Share Chart

Trading Update

21 Jul 2020 07:00

RNS Number : 5500T
KRM22 PLC
21 July 2020
 

KRM22 plc

("KRM22", the "Group" or the "Company")

Half Year Trading Update

 

KRM22 plc, (AIM: KRM) the technology and software investment company that focuses on risk management for capital markets, today issues the following trading update for the 6 months to 30 June 2020 (the "Period").

 

The first half has been impacted by the effects of COVID-19 but progress has been made with two new customer wins and cost and debt reduction in the Period.

 

As described in the trading update of 2 April 2020, the Company has experienced slowed business activity and extended sales cycles as customers and prospects have transitioned to home working and with the increased operational burden resulting from market volatility. Notwithstanding the backdrop, the Company has secured two new customers in the period and sold additional products to an existing customer adding an aggregate of £0.3m in ARR in the period resulting in a total ARR as at 30 June 2020 of £4.0m (which excludes the disputed contract with ARR of £0.3m as described below). The new contracts include the purchase of Enterprise and Market Risk products.

 

The total ARR of £4.0m is after the loss of four institutional customers who have terminated their contracts with the Company in the Period amounting to an aggregate of £0.3m ARR. These terminations were due to a variety of market factors and COVID-19 but are not related to the performance of the Company. As detailed in the trading update of 2 April 2020, the Company had disputed ARR of £0.4m from two customers. With one of these customers, the Company has now negotiated a contract at a lower value to retain them as a customer and assist their early stage development and this contract is now included in the ARR of £4.0m as described above. Discussions continue with the other customer to try and find a commercial resolution for the remaining £0.3m.

 

The Company continues to have a strong pipeline of opportunities and is progressing well through the procurement process with two further tier one banks which the Company expects will close in the second half of the year. The UK Brokerage referenced in the Company's trading update of 2 April 2020 is in the final stages of approval, will add a further £0.3m of ARR.

 

Costs and operations

 

As detailed in the update of 2 April 2020, the new contract wins, together with the cost reduction actions implemented, have resulted in a substantial reduction in adjusted EBITDA loss at the period end. This has been achieved through a combination of salary sacrifices across all staff in 2020, staff redundancies and general overhead reductions. The Company tracks the Group's booked ARR when compared to the cash burn run rate within the business and reports that this ratio is 1.27 as at the period end (compared to 1.59 in January 2020). As a result, the Group's total monthly cash recurring burn run rate in July from all operations will be £0.08m plus £0.03m for interest and capital repayments.

 

Cash as at 30 June 2020 was £0.8m (31 December 2019: £1.1m and 21 May 2020: £1.4m). The Group's debt as at 30 June 2020 reduced to £0.8m (31 December 2019: £2.0m) after the conversion of the Convertible loan note ("CLN"). As detailed in the announcement of 29 June 2020, the CLN was converted into 1,454,434 ordinary shares in the Company. The Harbert Debt facility remains in place with the ability to drawdown on the facility until 31 December 2020. In addition, the Company is in the process of finalising a further R&D tax claim with an initial submission of c. £0.2m.

 

Outlook

 

The first half has been impacted by the effects of COVID-19 but the Company remains encouraged by its pipeline of opportunities. The Company is focused on continuing to drive organic growth and has made good progress in the Period and remains confident of meeting management expectations for the year.

 

 

Keith Todd CBE, Executive Chairman and Chief Executive Officer at KRM22 commented: "The first half has been impacted by the effects of COVID-19 but I remain encouraged by our customer engagement. We have managed through these recent turbulent times and are on track to deliver the full year expectations. The outlook for our offering continues to be positive with a broad engagement of prospects in Europe, Asia and USA."

 

 

For further information please contact:

 

KRM22 plc InvestorRelations@krm22.com

Keith Todd CBE, Executive Chairman and CEO

Kim Suter, CFO

 

finnCap Ltd (Nominated Adviser and Sole Broker) +44 (0)20 7220 0500

Carl Holmes / Kate Bannatyne / Matthew Radley

Alice Lane / Sunila de Silva (ECM)

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

 

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management. The Global Risk Platform provides applications to help address firms' regulatory, market, technology and operations risk challenges and to manage their entire enterprise risk profile.

 

Capital markets companies' partner with KRM22 to optimise risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

 

KRM22 plc is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

 

See more about KRM22 at KRM22.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSEUFUSESSEEW
Date   Source Headline
26th May 20263:24 pmRNSHolding(s) in Company
26th May 20262:25 pmRNSHolding(s) in Company
22nd May 20267:00 amRNSDirector Dealings
20th May 202611:19 amRNSDirector Dealings
20th May 20267:00 amRNSNotice of AGM and Posting of Annual Report
13th May 20267:00 amRNSFinal Results
29th Jan 20267:00 amRNSTrading Update
7th Jan 20267:00 amRNSAppointment of Director
20th Nov 20254:12 pmRNSTR-1
11th Nov 20257:00 amRNSIssue of Equity
10th Nov 20259:28 amRNSHolding(s) in Company
5th Nov 20251:05 pmRNSResult of GM
15th Oct 20257:00 amRNSResult of Placing
14th Oct 20254:50 pmRNSProposed Placing and Subscription
17th Sep 20257:00 amRNSInterim Results
7th Aug 20257:00 amRNSTrading Update
21st Jul 20257:00 amRNSIssue of Equity
27th Jun 20252:10 pmRNSResult of AGM
6th Jun 20257:00 amRNSDirector Dealing
2nd Jun 20257:00 amRNSIssue of Restricted Stock Units
30th May 20257:00 amRNSNotice of AGM and Posting of Annual Report
21st May 20257:00 amRNSDirector Dealing
19th May 20257:00 amRNSFinal Results
29th Apr 20257:00 amRNSFacility Amendment
7th Apr 20257:00 amRNSNew Customer Contracts
1st Apr 20257:00 amRNSFacility Amendment
18th Mar 20257:00 amRNSIssue of Equity
4th Mar 20257:00 amRNSNew Customer Contract
13th Feb 20255:00 pmRNSDirector Dealing
22nd Jan 20257:00 amRNSTrading Update
10th Jan 20257:00 amRNSIssue of Equity
23rd Dec 20247:00 amRNSLoan Facility Amendment
15th Oct 20247:00 amRNSIssue of Equity
25th Sep 20247:00 amRNSInterim Results
3rd Sep 20247:00 amRNSChange of Registered Office
29th Aug 20247:00 amRNSNew Customer Contract
22nd Aug 202410:00 amRNSGrant of Options and Director/PDMR Shareholding
19th Aug 20247:00 amRNSIssue of Equity
18th Jul 20247:00 amRNSHalf Year Trading Update
21st Jun 202412:49 pmRNSResult of AGM
29th May 20247:00 amRNSNotice of AGM and Posting of Annual Report
22nd May 20247:00 amRNSFinal Results
16th Apr 20247:00 amRNSDirector Dealings
15th Apr 20247:00 amRNSNew Customer Contract
10th Apr 20247:00 amRNSIssue of Equity
7th Mar 20247:00 amRNSBoard Changes
21st Feb 20247:00 amRNSTrading Update
1st Dec 20237:00 amRNSIssue of Restricted Stock Units
26th Sep 20237:00 amRNSInterim Results
27th Jul 202311:48 amRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.